Literature DB >> 6408178

Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells.

M E Hemler, C F Ware, J L Strominger.   

Abstract

By using a single monoclonal antibody, a novel glycoprotein complex composed of at least three distinct bands was defined on the surface of mitogen- or alloantigen-stimulated T cells. These bands (210,000, 165,000, and 130,000 Mr) were not disulfide linked and could be radio-labeled with 125I or 35S-methionine and readily detected by immunoprecipitation with the monoclonal antibody A-1A5. Only approximately 20% of normal T cells (E rosette positive) and approximately 47% non-T cells (E rosette negative) were reactive with A-1A5. However, upon activation of T cells, the amount of A-1A5 binding per cell and the percentage of positive cells significantly increased. This increase was most pronounced in the activated cell subpopulations currently undergoing cell division (S, G2, and M phases), which became 79% A-1A5 positive (after PHA stimulation) and 99% A-1A5 positive (in long-term culture with alloantigen and IL2). Resting lymphocytes contained only the 130,000 Mr band reactive with A-1A5. The two other bands (210,000 and 165,000 Mr) were markers for T cell activation and only appeared several days after T cell stimulation and became especially prominent after the addition of exogenous IL 2. All T lymphoblastoid cell lines tested expressed at least the lower bands (130,000 Mr), and the T cell line HSB also expressed one of the activation-related larger proteins (165,000 Mr). B lymphoblastoid cell lines expressed only a very weak lower band (130,000 Mr), and the cell line U-937 (in the monocyte-macrophage lineage) expressed only a single band (145,000 Mr) not aligned with any of the bands found on lymphoid cells. The estimated number of A-1A5 binding sites per cell was much higher on U-937 (11 X 10(5)), and generally higher on other cell lines of myeloid lineage (1 to 4 X 10(5)) than on lymphoid cell lines (0.2 to 1.3 X 10(5)).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408178

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Role of beta 1-integrins in epidermotropism of malignant T cells.

Authors:  W Sterry; V Mielke; U Konter; I Kellner; W H Boehncke
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

2.  A family of beta 7 integrins on human mucosal lymphocytes.

Authors:  C M Parker; K L Cepek; G J Russell; S K Shaw; D N Posnett; R Schwarting; M B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

3.  Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ.

Authors:  Vera Novitskaya; Hanna Romanska; Marwa Dawoud; J Louise Jones; Fedor Berditchevski
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 4.  Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there.

Authors:  Christopher C Denucci; Jason S Mitchell; Yoji Shimizu
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

5.  The integrin VLA-2 binds echovirus 1 and extracellular matrix ligands by different mechanisms.

Authors:  J M Bergelson; B M Chan; R W Finberg; M E Hemler
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins).

Authors:  F Berditchevski; M M Zutter; M E Hemler
Journal:  Mol Biol Cell       Date:  1996-02       Impact factor: 4.138

7.  Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells.

Authors:  M E Hemler; M B Brenner; J M McLean; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines.

Authors:  C M Witkowski; I Rabinovitz; R B Nagle; K S Affinito; A E Cress
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Integrins as differential cell lineage markers of primary liver tumors.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Increased expression of laminin/collagen receptor (VLA-1) on epithelium of inflamed human intestine.

Authors:  T T MacDonald; M A Horton; M Y Choy; P I Richman
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.